Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for ph all
Most Relevant Literature
- Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?
- Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.
- A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL underg…
- Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab …
- CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apopt…
Most Relevant Clinical Trials
- Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
- CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
- A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
- The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or W…
